Which high-risk infants should we follow-up and how should we do it?

被引:30
|
作者
Walker, Karen [1 ]
Holland, Andrew J. A. [2 ]
Halliday, Robert [1 ]
Badawi, Nadia [1 ]
机构
[1] Univ Sydney, Sydney Med Sch, Grace Ctr Newborn Care, Childrens Hosp Westmead, Sydney, NSW 2006, Australia
[2] Univ Sydney, Sydney Med Sch, Childrens Hosp,Westmead, Douglas Cohen Dept Paediat Surg, Sydney, NSW 2006, Australia
关键词
developmental; neonatal surgery; neonatology; PRETERM INFANTS; NEURODEVELOPMENTAL OUTCOMES; BEHAVIORAL OUTCOMES; COGNITIVE OUTCOMES; DEVELOPING BRAIN; EARLY EXPOSURE; CHILDREN; INTERVENTION; ANESTHESIA; SURGERY;
D O I
10.1111/j.1440-1754.2012.02540.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Early detection of neurodevelopmental delay and appropriate intervention has been associated with improved academic and social outcomes. Identifying those who are at high risk and might benefit is not straightforward. Approximately 2% of infants are admitted to a neonatal intensive care unit after birth and these babies are known to be at high risk of developmental impairment. While it is well recognised that the extreme preterm infant is at high risk of developmental impairment, there is increasing evidence of a risk in late preterm infants as well as those undergoing major cardiac and non-cardiac surgery. Not all infants are enrolled in multidisciplinary follow-up clinics with easy access to early intervention. These clinics are expensive to run with both limited and conflicting data on their long-term value. This review will concentrate on identifying which infants are at risk, reviewing the aetiology of the risk factors and the efficacy of follow-up clinics.
引用
收藏
页码:789 / 793
页数:5
相关论文
共 50 条
  • [1] How should we follow-up patients undergoing CRT?
    Kolettis, Theofilos M.
    [J]. HELLENIC JOURNAL OF CARDIOLOGY, 2018, 59 (04) : 232 - 233
  • [2] Vulvar melanoma: How good are we in the follow-up of high-risk women?
    Tosti, Giulio
    Barisani, Alessia
    Iacobone, Anna Daniela
    Preti, Eleonora Petra
    Pirola, Sara
    Salvini, Camilla
    Pennacchioli, Elisabetta
    Vaccari, Sabina
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [3] Systematic pulmonary embolism follow-up: why we should all do it!
    Howard, Luke S.
    Price, Laura C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (03)
  • [4] Hemoptysis: How far should we workup and who should we follow?
    Chan, King-Pui Florence
    Lam, David Chi-Leung
    Ip, Mary Sau-Man
    Tam, Terence Chi-Chun
    [J]. RESPIROLOGY, 2023, 28 : 189 - 189
  • [5] Should we treat pyrexia? And how do we do it?
    Doyle, James F.
    Schortgen, Frederique
    [J]. CRITICAL CARE, 2016, 20
  • [6] Should we treat pyrexia? And how do we do it?
    James F. Doyle
    Frédérique Schortgen
    [J]. Critical Care, 20
  • [7] CHOLESTEROL POLICY - WHAT SHOULD WE DO - HOW SHOULD WE DECIDE
    KOTTKE, TE
    BREKKE, ML
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (10) : 1023 - 1027
  • [8] Postregistration trials: Should we? How do we?
    Del Sorbo, Lorenzo
    Thompson, B. Taylor
    Ranieri, V. Marco
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (01) : S154 - S158
  • [9] Which systematic review should we follow?
    Zou, Kun
    Zhang, Weiya
    [J]. RHEUMATOLOGY, 2013, 52 (05) : 763 - 764
  • [10] Symptoms versus testing: How should we follow-up achalasia after myotomy?
    van Berkel, Victor
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (02): : 869 - 870